Literature DB >> 12773701

Regulation of vascular endothelial growth factor gene expression in murine macrophages by nitric oxide and hypoxia.

Madhuri Ramanathan1, Avi Giladi, S Joseph Leibovich.   

Abstract

Vascular endothelial growth factor (VEGF) expression in murine peritoneal macrophages is strongly upregulated by hypoxia via transcriptional and posttranscriptional mechanisms. Interferon-gamma (IFN-gamma) with Escherichia coli lipopolysaccharide (LPS) also upregulates expression of VEGF, as well as of the inducible nitric oxide synthase (iNOS). Hypoxia (1% O(2)) upregulates VEGF expression in macrophages from both wild-type and iNOS knockout mice, indicating that hypoxic upregulation of VEGF is independent of iNOS. However, the iNOS inhibitor aminoguanidine (AG) decreases the VEGF expression induced by LPS/IFN-gamma, indicating an important role for NO. NO-dependent induction of VEGF is strongly dependent on cell density. LPS/IFN-gamma treatment induces minimal VEGF protein expression in macrophages cultured at low cell densities (<0.25 x 10(6) cells/cm(2)); at higher cell densities (>0.25 x 10(6) cells/cm(2)) that lead to conditions of pericellular hypoxia, however, induction of VEGF expression was strong. Transient transfection of RAW 264.7 cells with luciferase reporter constructs of the murine VEGF promoter indicates that both hypoxia and LPS/IFN-gamma independently induce VEGF promoter activity, irrespective of cell density. Although LPS/IFN-gamma treatment induces transcriptional activation of the VEGF promoter, significant levels of VEGF protein are only expressed by cells at high density under conditions of pericellular hypoxia. This suggests an important regulatory role for hypoxia at the posttranscriptional level. Deletion analysis of the VEGF promoter shows that the hypoxia response element region and its immediate flanking sequences are essential for both hypoxia and LPS/IFN-gamma-induced VEGF promoter activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773701     DOI: 10.1177/153537020322800608

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  22 in total

1.  Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter.

Authors:  Madhuri Ramanathan; Grace Pinhal-Enfield; Irene Hao; Samuel Joseph Leibovich
Journal:  Mol Biol Cell       Date:  2006-10-25       Impact factor: 4.138

2.  Lipopolysaccharide-induced proliferation of the vasa vasorum in a rabbit model of atherosclerosis as evaluated by contrast-enhanced ultrasound imaging and histology.

Authors:  Jinwei Tian; Sining Hu; Xue Han; Nana Dong; Huai Yu; Yanli Sun; Bo Yu
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

3.  Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC).

Authors:  Chenghai Li; Bin Liu; Zonghan Dai; Yunxia Tao
Journal:  Cancer Biol Ther       Date:  2011-11-15       Impact factor: 4.742

4.  Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lung.

Authors:  Vineet Bhandari; Rayman Choo-Wing; Svetlana P Chapoval; Chun G Lee; C Tang; Y K Kim; Bing Ma; Peter Baluk; Michelle I Lin; Donald M McDonald; Robert J Homer; William C Sessa; Jack A Elias
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-10       Impact factor: 11.205

5.  Effective antitumour mono- and combination therapy by gene delivery of angiostatin-like molecule and interleukin-12 in a murine hepatoma model.

Authors:  Volker Schmitz; Lucia Tirado-Ledo; Esther Raskopf; Christian Rabe; Nicolas Wernert; Lin Wang; Jesús Prieto; Cheng Qian; Tilman Sauerbruch; Wolfgang H Caselmann
Journal:  Int J Colorectal Dis       Date:  2005-04-30       Impact factor: 2.571

6.  Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis.

Authors:  Bumseok Kim; Qingquan Tang; Partha S Biswas; Jun Xu; Raymond M Schiffelers; Frank Y Xie; Aslam M Ansari; Puthupparampil V Scaria; Martin C Woodle; Patrick Lu; Barry T Rouse
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

7.  Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth.

Authors:  Scott A Gerber; Viktoriya Y Rybalko; Chad E Bigelow; Amit A Lugade; Thomas H Foster; John G Frelinger; Edith M Lord
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

8.  Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors.

Authors:  Lisa Macedo; Grace Pinhal-Enfield; Vera Alshits; Genie Elson; Bruce Neil Cronstein; Samuel Joseph Leibovich
Journal:  Am J Pathol       Date:  2007-11-01       Impact factor: 4.307

9.  Suppression of PLCbeta2 by endotoxin plays a role in the adenosine A(2A) receptor-mediated switch of macrophages from an inflammatory to an angiogenic phenotype.

Authors:  Stan Grinberg; Gyorgy Hasko; Dianqing Wu; Samuel Joseph Leibovich
Journal:  Am J Pathol       Date:  2009-10-22       Impact factor: 4.307

10.  Differential regulation of HIF-1alpha isoforms in murine macrophages by TLR4 and adenosine A(2A) receptor agonists.

Authors:  Madhuri Ramanathan; Wenting Luo; Balázs Csóka; György Haskó; Dmitry Lukashev; Michail V Sitkovsky; Samuel Joseph Leibovich
Journal:  J Leukoc Biol       Date:  2009-05-28       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.